{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:19:03Z","timestamp":1777663143580,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012544","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bcp.2026.117859","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:22:20Z","timestamp":1772497340000},"page":"117859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic interference of SREBP-mediated lipid metabolism by E-Xanthohumol attenuates prostate cancer progression"],"prefix":"10.1016","volume":"248","author":[{"given":"Jonathan","family":"Viehoever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen Surya","family":"Velmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vignesh","family":"Basavaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lahiru","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveenkumar","family":"Basavaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2342-9099","authenticated-orcid":false,"given":"Wen-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117859_b0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"74","key":"10.1016\/j.bcp.2026.117859_b0010","first-page":"229","article-title":"Global cancer statistics 2022 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"2024","author":"Bray","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.117859_b0015","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbamcr.2016.02.016","article-title":"The molecular and cellular origin of human prostate cancer","volume":"1863","author":"Packer","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.117859_b0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Revv. Cancer"},{"key":"10.1016\/j.bcp.2026.117859_b0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrurol.2018.9","article-title":"Clinical implications of PTEN loss in prostate cancer","volume":"15","author":"Jamaspishvili","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bcp.2026.117859_b0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1158\/1541-7786.MCR-11-0451","article-title":"Caveolin-1 upregulation contributes to c-Myc\u2013induced high-grade prostatic intraepithelial neoplasia and prostate cancer","volume":"10","author":"Yang","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117859_b0035","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.3390\/ijms26083826","article-title":"A pathway to genomic complexity and cancer development","volume":"26","author":"Pellestor","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117859_b0040","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s41388-018-0583-7","article-title":"Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells","volume":"38","author":"He","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117859_b0045","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JME-14-0203","article-title":"Androgens and androgen receptor signaling in prostate tumorigenesis","volume":"54","author":"Zhou","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117859_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000040","article-title":"International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries","volume":"1","author":"Liede","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.bcp.2026.117859_b0055","article-title":"Trends in androgen deprivation use in men with intermediate-risk prostate cancer who underwent radiation therapy","volume":"7","author":"Agrawal","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.bcp.2026.117859_b0060","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1530\/EC-17-0118","article-title":"Clinical relevance of androgen receptor alterations in prostate cancer","volume":"6","author":"Jernberg","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.bcp.2026.117859_b0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.117859_b0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ccell.2017.09.011","article-title":"Cellular origin of androgen receptor pathway-independent prostate cancer and implications for therapy","volume":"32","author":"Brennen","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.117859_b0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.eururo.2020.04.061","article-title":"Five-year survival prediction and safety outcomes with enzalutamide in men with chemotherapy-na\u00efve metastatic castration-resistant prostate cancer from the PREVAIL trial","volume":"78","author":"Armstrong","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bcp.2026.117859_b0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bcp.2026.117859_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bcp.2026.117859_b0090","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1073\/pnas.90.24.11603","article-title":"SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element","volume":"90","author":"Hua","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2026.117859_b0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","article-title":"SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene","volume":"75","author":"Yokoyama","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117859_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000446","article-title":"EGFR signaling through an Akt-SREBP-1\u2013dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy","volume":"2","author":"Guo","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bcp.2026.117859_b0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0014-4827(02)00023-X","article-title":"Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c","volume":"282","author":"Yang","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.117859_b0110","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3892\/ol.2016.4988","article-title":"SREBP\u20111 is an independent prognostic marker and promotes invasion and migration in breast cancer","volume":"12","author":"Bao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2026.117859_b0115","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1007\/s13277-015-3047-5","article-title":"SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism","volume":"36","author":"Sun","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bcp.2026.117859_b0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbadis.2018.10.026","article-title":"SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis","volume":"1865","author":"Jie","year":"2019","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.117859_b0125","first-page":"3003","article-title":"SREBP2 is upregulated in esophageal squamous cell carcinoma and co\u2011operates with c\u2011Myc to regulate HMGCR expression","volume":"20","author":"Zhong","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2026.117859_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/1541-7786.MCR-11-0206","article-title":"Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells","volume":"10","author":"Huang","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117859_b0135","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1158\/0008-5472.CAN-2148-2","article-title":"Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence","volume":"64","author":"Ettinger","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117859_b0140","doi-asserted-by":"crossref","first-page":"12869","DOI":"10.18632\/oncotarget.7331","article-title":"SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.117859_b0145","doi-asserted-by":"crossref","first-page":"41018","DOI":"10.18632\/oncotarget.5879","article-title":"Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.117859_b0150","doi-asserted-by":"crossref","first-page":"108181","DOI":"10.18632\/oncotarget.22569","article-title":"SREBP-2-driven transcriptional activation of human SND1 oncogene","volume":"8","author":"Armengol","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.117859_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040914","article-title":"Emerging therapeutic activity of Davallia formosana on prostate cancer cells through coordinated blockade of lipogenesis and androgen receptor expression","volume":"12","author":"Hsieh","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.117859_b0160","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/life12111769","article-title":"Alpinumisoflavone exhibits the therapeutic effect on prostate cancer cells by repressing AR and Co-targeting FASN-and HMGCR-mediated lipid and cholesterol biosynthesis","volume":"12","author":"Basavaraj","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.bcp.2026.117859_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153806","article-title":"Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1\/FASN-driven metabolism and AR","volume":"93","author":"Hsieh","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117859_b0170","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.3390\/molecules23102539","article-title":"Ganoderma tsugae inhibits the SREBP-1\/AR axis leading to suppression of cell growth and activation of apoptosis in prostate cancer cells","volume":"23","author":"Huang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117859_b0175","first-page":"20","article-title":"Chinese herbal medicine Ganoderma tsugae displays potential anti-cancer efficacy on metastatic prostate cancer cells","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117859_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114948","article-title":"Elucidation of scandenolone as anti-cancer activity through impairment of the metabolic and signaling vulnerabilities in prostate cancer","volume":"164","author":"Basavaraj","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117859_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2020.117196","article-title":"Simple and green method for the extraction of xanthohumol from spent hops using deep eutectic solvents","volume":"250","author":"Grudniewska","year":"2020","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.bcp.2026.117859_b0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12986-018-0277-8","article-title":"Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway","volume":"15","author":"Samuels","year":"2018","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.bcp.2026.117859_b0195","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s10495-007-0130-4","article-title":"Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis","volume":"12","author":"Yang","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2026.117859_b0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jnutbio.2017.03.006","article-title":"Xanthohumol and 8-prenylnaringenin ameliorate diabetic-related metabolic dysfunctions in mice","volume":"45","author":"Costa","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bcp.2026.117859_b0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2016.03.008","article-title":"Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL\/6J mice","volume":"599","author":"Miranda","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2026.117859_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116598","article-title":"Xanthohumol, a prenylated chalcone, regulates lipid metabolism by modulating the LXR\u03b1\/RXR-ANGPTL3-LPL axis in hepatic cell lines and high-fat diet-fed zebrafish models","volume":"174","author":"Gao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117859_b0215","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1074\/jbc.M115.656975","article-title":"Xanthohumol improves diet-induced obesity and fatty liver by suppressing sterol regulatory element-binding protein (SREBP) activation","volume":"290","author":"Miyata","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117859_b0220","first-page":"2025","article-title":"Anti-metastatic effects of scandenolone: a natural prenylated isoflavonoid on prostate cancer cells","volume":"10","author":"Basavaraj","year":"2025","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bcp.2026.117859_b0225","doi-asserted-by":"crossref","first-page":"W390","DOI":"10.1093\/nar\/gkae335","article-title":"LipidSig 2.0: integrating lipid characteristic insights into advanced lipidomics data analysis","volume":"52","author":"Liu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.117859_b0230","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.molcel.2007.03.017","article-title":"The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope","volume":"26","author":"Mancias","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.117859_b0235","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gky357","article-title":"HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm","volume":"46","author":"Zhou","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.117859_b0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2026.117859_b0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors","volume":"54","author":"Vir\u00e1g","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.117859_b0250","first-page":"778","article-title":"Lipid metabolism and carcinogenesis, cancer development","volume":"8","author":"Long","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117859_b0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.117859_b0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/5584_2024_832","article-title":"PI3K signaling at the crossroads of lipid metabolism and cancer","volume":"1479","author":"Yilmaz","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2026.117859_b0265","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3390\/ijms24032289","article-title":"Addressing the reciprocal crosstalk between the AR and the PI3K\/AKT\/mTOR signaling pathways for prostate cancer treatment","volume":"24","author":"Raith","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117859_b0270","first-page":"22","article-title":"Xanthohumol for human malignancies: chemistry, pharmacokinetics and molecular targets","author":"Harish","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117859_b0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12935-023-03009-2","article-title":"Xanthohumol hinders invasion and cell cycle progression in cancer cells through targeting MMP2, MMP9, FAK and P53 genes in three-dimensional breast and lung cancer cells culture","volume":"23","author":"Gholizadeh Siahmazgi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2026.117859_b0280","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.3390\/ijms22094478","article-title":"Xanthohumol for human malignancies: chemistry, pharmacokinetics and molecular targets","volume":"22","author":"Harish","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117859_b0285","first-page":"20","article-title":"Lipid metabolism and endocrine resistance in prostate cancer, and new opportunities for therapy","author":"Stoykova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117859_b0290","article-title":"Lipid droplets in prostate cancer cells and effect of irradiation studied by Raman microspectroscopy","volume":"1865","author":"Roman","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.117859_b0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neo.2021.11.004","article-title":"Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer","volume":"24","author":"Wang","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2026.117859_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-021-00278-1","article-title":"Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover","volume":"10","author":"Raftopulos","year":"2022","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bcp.2026.117859_b0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12301-022-00295-6","article-title":"The impact of androgen deprivation therapy on the lipid profile in patients with prostate carcinoma","volume":"28","author":"Kumar","year":"2022","journal-title":"Afr. J. Urol."},{"key":"10.1016\/j.bcp.2026.117859_b0310","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s12276-020-0430-0","article-title":"The cellular function of SCAP in metabolic signaling","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2026.117859_b0315","doi-asserted-by":"crossref","first-page":"31078","DOI":"10.1074\/jbc.M005353200","article-title":"Promoter analysis of the mouse sterol regulatory element-binding protein-1c Gene*","volume":"275","author":"Amemiya-Kudo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117859_b0320","doi-asserted-by":"crossref","first-page":"26461","DOI":"10.1074\/jbc.271.43.26461","article-title":"Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2*","volume":"271","author":"Sato","year":"1996","journal-title":"JBC"},{"key":"10.1016\/j.bcp.2026.117859_b0325","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1074\/jbc.M109.092759","article-title":"Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK\/lipogenic pathway in human prostate cancer cells","volume":"285","author":"Huang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117859_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202100831","article-title":"Bioavailability and cardiometabolic effects of xanthohumol: evidence from animal and human studies","volume":"66","author":"Neumann","year":"2022","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:31:28Z","timestamp":1777447888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"alternative-id":["S0006295226001917"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117859","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic interference of SREBP-mediated lipid metabolism by E-Xanthohumol attenuates prostate cancer progression","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117859"}}